These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
146 related articles for article (PubMed ID: 25927726)
1. Target specific proteochemometric model development for BACE1 - protein flexibility and structural water are critical in virtual screening. Manoharan P; Chennoju K; Ghoshal N Mol Biosyst; 2015 Jul; 11(7):1955-72. PubMed ID: 25927726 [TBL] [Abstract][Full Text] [Related]
2. Screening and Elucidation of Selected Natural Compounds for Anti- Alzheimer's Potential Targeting BACE-1 Enzyme: A Case Computational Study. Ahmad SS; Akhtar S; Danish Rizvi SM; Kamal MA; Sayeed U; Khan MKA; Siddiqui MH; Arif JM Curr Comput Aided Drug Des; 2017 Nov; 13(4):311-318. PubMed ID: 28413992 [TBL] [Abstract][Full Text] [Related]
3. Encompassing receptor flexibility in virtual screening using ensemble docking-based hybrid QSAR: discovery of novel phytochemicals for BACE1 inhibition. Chakraborty S; Ramachandran B; Basu S Mol Biosyst; 2014 Oct; 10(10):2684-92. PubMed ID: 25088750 [TBL] [Abstract][Full Text] [Related]
4. Conformational transition in the substrate binding domain of β-secretase exploited by NMA and its implication in inhibitor recognition: BACE1-myricetin a case study. Chakraborty S; Kumar S; Basu S Neurochem Int; 2011 Jul; 58(8):914-23. PubMed ID: 21354237 [TBL] [Abstract][Full Text] [Related]
5. Flexibility of the flap in the active site of BACE1 as revealed by crystal structures and molecular dynamics simulations. Xu Y; Li MJ; Greenblatt H; Chen W; Paz A; Dym O; Peleg Y; Chen T; Shen X; He J; Jiang H; Silman I; Sussman JL Acta Crystallogr D Biol Crystallogr; 2012 Jan; 68(Pt 1):13-25. PubMed ID: 22194329 [TBL] [Abstract][Full Text] [Related]
6. BACE1 molecular docking and anti-Alzheimer's disease activities of ginsenosides. Choi RJ; Roy A; Jung HJ; Ali MY; Min BS; Park CH; Yokozawa T; Fan TP; Choi JS; Jung HA J Ethnopharmacol; 2016 Aug; 190():219-30. PubMed ID: 27275774 [TBL] [Abstract][Full Text] [Related]
7. Molecular insights into the inhibitory mechanism of bi-functional bis-tryptoline triazole against β-secretase (BACE1) enzyme. Narang SS; Goyal D; Goyal B Amino Acids; 2019 Nov; 51(10-12):1593-1607. PubMed ID: 31654211 [TBL] [Abstract][Full Text] [Related]
8. Polymethoxyflavones: Novel β-Secretase (BACE1) Inhibitors from Citrus Peels. Youn K; Yu Y; Lee J; Jeong WS; Ho CT; Jun M Nutrients; 2017 Sep; 9(9):. PubMed ID: 28869548 [TBL] [Abstract][Full Text] [Related]
9. Acylguanidine-BACE1 complex: Insights of intermolecular interactions and dynamics. Saravanan K; Kumaradhas P J Theor Biol; 2019 Mar; 464():33-49. PubMed ID: 30571961 [TBL] [Abstract][Full Text] [Related]
10. Computational analysis of BACE1-ligand complex crystal structures and linear discriminant analysis for identification of BACE1 inhibitors with anti P-glycoprotein binding property. Manoharan P; Chennoju K; Ghoshal N J Biomol Struct Dyn; 2018 Jan; 36(1):262-276. PubMed ID: 28081663 [TBL] [Abstract][Full Text] [Related]
11. Identification of BACE1 inhibitors from Panax ginseng saponins-An Insilco approach. Karpagam V; Sathishkumar N; Sathiyamoorthy S; Rasappan P; Shila S; Kim YJ; Yang DC Comput Biol Med; 2013 Sep; 43(8):1037-44. PubMed ID: 23816176 [TBL] [Abstract][Full Text] [Related]
12. Asp32 and Asp228 determine the selective inhibition of BACE1 as shown by docking and molecular dynamics simulations. Hernández-Rodríguez M; Correa-Basurto J; Gutiérrez A; Vitorica J; Rosales-Hernández MC Eur J Med Chem; 2016 Nov; 124():1142-1154. PubMed ID: 27639619 [TBL] [Abstract][Full Text] [Related]
13. Is BACE1 a suitable therapeutic target for the treatment of Alzheimer's disease? Current strategies and future directions. Klaver DW; Wilce MC; Cui H; Hung AC; Gasperini R; Foa L; Small DH Biol Chem; 2010 Aug; 391(8):849-59. PubMed ID: 20731541 [TBL] [Abstract][Full Text] [Related]